|
CDKN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60129998150182E-09 |
| Normal-vs-Stage2 |
1.042410E-02 |
| Normal-vs-Stage3 |
6.56180000002671E-07 |
| Normal-vs-Stage4 |
1.254080E-02 |
| Stage1-vs-Stage2 |
7.620600E-01 |
| Stage1-vs-Stage3 |
2.215400E-04 |
| Stage1-vs-Stage4 |
4.567800E-02 |
| Stage2-vs-Stage3 |
2.822200E-04 |
| Stage2-vs-Stage4 |
4.000100E-02 |
| Stage3-vs-Stage4 |
5.456200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62614366416847E-12 |
| Normal-vs-AfricanAmerican |
6.66439999852386E-08 |
| Normal-vs-Asian |
2.791800E-02 |
| Caucasian-vs-AfricanAmerican |
1.014190E-01 |
| Caucasian-vs-Asian |
1.267040E-01 |
| AfricanAmerican-vs-Asian |
1.105770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
2.14140000176499E-08 |
| Male-vs-Female |
8.335600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.87315999999882E-05 |
| Normal-vs-Extreme_Weight |
3.09390291164391E-11 |
| Normal-vs-Obese |
2.54359999996012E-06 |
| Normal-vs-Extreme_Obese |
7.300300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.014600E-01 |
| Normal_Weight-vs-Obese |
5.609800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.278400E-02 |
| Extreme_Weight-vs-Obese |
6.426100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.454600E-01 |
| Obese-vs-Extreme_Obese |
1.435900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.841300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.81720202721658E-11 |
| Normal-vs-Age(61-80Yrs) |
6.60929977414071E-10 |
| Normal-vs-Age(81-100Yrs) |
1.936750E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.025630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.283900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.050200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.269600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.088600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.134400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
5.67750000346479E-08 |
| Normal-VS-KIRP CIMP |
8.398600E-04 |
| Normal-VS-Unclassified PRCC |
7.60120000000697E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.696810E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.200000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.283180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.70699999999724E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.533830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.358800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7886000000007E-05 |
| Normal-vs-N1 |
2.28700000048931E-07 |
| Normal-vs-N2 |
1.055640E-01 |
| N0-vs-N1 |
5.93979999999883E-05 |
| N0-vs-N2 |
5.416400E-01 |
| N1-vs-N2 |
2.126600E-01 |
|
|
